Medicine preparations for the attenuation of colds. Ephedrae Herba is one of the prescriptions of Sho-seiryu-to. The major ingredients of Ephedrae Herba, ephedrines, are banned substances on the World Anti-Doping Agency (WADA) list. The purpose of this study was to investigate the elimination of urinary ephedrines after administering Sho-seiryu-to preparation and to determine the possibility of positive ephedrines test results in urine. Six healthy volunteers took a single 2.5-g dose of concentrated Sho-seiryu-to preparation. All urine was collected for 48 h. The concentrations of urinary ephedrines were analyzed by high-performance liquid chromatography and the elimination half-life of the ephedrines was estimated. The results show that ephedrine and cathine (norpseudoephedrine), the prohibited substances of the WADA, were excreted in the urine after taking a single dose of Sho-seiryuto preparation. The peak concentration of ephedrine was 3.88 ± 1.87 mg/mL (mean ± SD), which was lower than the WADA permitted value (10 mg/mL). The estimated elimination half-lives of ephedrine, norephedrine, pseudoephedrine, and norpseudoephedrine following administration of this preparation were 5.3 ± 1.2, 4.9 ± 0.9, 4.4 ± 1.0, and 5.4 ± 1.8 h, respectively. This study concluded that the urine would not violate the antidoping rules after administering a single dose of Sho-seiryu-to preparation. Nevertheless, an applied multiple-dose study upon administering the preparation for three times per day for three days showed a positive urine ephedrine result (13.7 mg/mL). Athletes should be careful when taking more than a single dose of Sho-seiryu-to preparation.
Introduction
Traditional Chinese Medicine (TCM) preparations are blended herbal medicines made from numerous crude components of natural origin. They have become more popular worldwide (1, 2) . Sho-seiryu-to, a mixture of eight crude extracts, Ephedrae Herba, Paeoniae Radix, Schisandrae Fructus, Zingiberis Siccatum Rhizoma, Glycyrrhizae Radix preparata, Cinnamomi Ramulus, Pinelliae Rhizoma, and Asiasari Radix, is one of the TCM preparations commonly used to alleviate the symptoms of fever, asthma, and cough.
Ephedrae herba (Ma Huang), its isolated alkaloids, collectively called ephedra alkaloids, is presented in the crude extraction and consists of three pairs of optically active stereoisomers: ephedrines, including ephedrine (E), pseudoephedrine (PE), norephedrine (NE, phenylpropanolamine), norpseudoephedrine (NPE, cathine), methylephedrine (ME), and methylpseudoephedrine (MPE) (3) . NE, NPE, E, PE, ME, and their relative substances (such as MPE) are included in a list of prohibited substances by the World Anti-Doping Agency (WADA) because of their potential as central nervous system stimulants. The WADA has set permitted levels below which the presence of these ephedrines in urine will not be regarded as a positive doping case. These limits are 5 µg/mL for NPE and 10 µg/mL for E and ME (4) . Because the main components of Ephedrae herba are prohibited by the WADA, an athlete may violate an anti-doping rule if he/she takes Sho-seiryu-to preparation.
For years, athletes have tested positive for these substances, but many have claimed they took the drugs inadvertently in over-the-counter (OTC) cough and cold preparations. Study has shown that 80% of OTC cold medicines in Taiwan contained banned ephedrines in their ingredients lists (5) . In Taiwan, during 1999-2001, the majority of positive specimens in athletes' urine were ephedrines (6) . Indeed, TCM is widely used as an alternative medicine. Some athletes admitted that they took Sho-seiryu-to preparation to alleviate a cold. Articles have been published on the topic of ephedrines in Sho-seiryuto preparation (7, 8) . However, the motive of these papers was to validate the analysis method for herbal medicines containing Ephedrae herba. Therefore, the excretion evidence for ephedrine alkaloids following administration of Sho-seiryu-to preparation is still unknown. The purpose of this study was to investigate the elimination of urinary ephedrine alkaloids after administering Sho-seiryu-to preparation and to determine the possibility of urinary positive ephedrines test results.
Materials and Methods

Materials
Ephedrine hydrochloride, pseudoephedrine hydrochloride, and methylephedrine hydrochloride standards were obtained from the Taiwan Biotech (Taoyuan, Taiwan). Norpseudoephedrine hydrochloride, norephedrine hydrochloride, methylpseudoephedrine, and α-ethylbenzylamine (1-phenylpropylamine, internal standard) were obtained from the Sigma-Aldrich Chemical (St. Louis, MO). The concentrated Sho-seiryu-to preparation (powder) was generously donated by Sun Ten Pharmaceutical (Taipei, Taiwan). Tetraethylammonium hydroxide (TEAH, 20%) and phosphoric acid (89%) were purchased from Merck (Darmstadt, Germany). Methanol and diethyl ether were obtained from BDH Laboratory Supplies (Dorset, England). All other chemicals were of analytical grade. Double deionized water was obtained from a Millipore Direct-Q5 system (Bedford, MA) and used throughout the study.
Drug administration and sample collection
Six healthy volunteers (three women and three men), with a mean age (± SD) of 24.5 (± 1.6) years, weight of 61.2 (± 10.8) kg, height of 166.0 (± 3.1) cm, participated in the experiment. The study was approved by the Human Research Ethics Committee of the National Taiwan Sport University (Taoyuan, Taiwan).
After an overnight fast, the subjects drank 100 mL water at 1.5, 1, and 0.5 hr before taking the Sho-seiryu-to preparation. A therapeutic dose (suggested by the manufacturer) of 2.5 g Sho-seiryu-to preparation was administered to each subject with 100 mL water. Following administration, urine samples were collected in polyethylene bottles in the intervals 0-0.5, 0.5-1, 1-1.5, 1.5-2, 2-2.5, 2.5-3, 3-6, 6-9, 9-12, 12-24, 24-36, and 36-48 h. To ensure sufficient urine flow during sampling, 100 mL of water was taken orally at 0.5, 1, 1.5, 2, 2.5, 3, 6, 9, and 12 h on treatment day. The volume, pH, and specific gravity of each urine sample at room temperature were recorded and stored at -20°C until analyzed.
A multiple-dose administration study was further applied to confirm the possibility of a positive urinary test result. One subject took Sho-seiryu-to preparation 2.5 g (with 100 mL water) three times per day after meals for three days as a regular treatment situation for alleviation the cold. Thereafter, all urines produced on the 4th, 5th, and 6th days were collected in polyethylene bottles and stored at -20°C until analyzed.
Drug analysis
Single-dose amounts of the Sho-seiryu-to preparation (2.5 g) were weighed. The extraction procedure for the preparation followed that described by Zhang et al. (3) . To the residue, 300 µL of 4 M HCl solution and 1 mL of α-ethylbenzylamine (internal standard) were added. The mixture was made up to a total volume of 50 mL with TEAP. A 20-µL aliquot of the extraction solution was injected into the HPLC system for analysis. The limits of detection (LOD) and quantitation (LOQ) for E and ME were 0.2 and 0.6 µg/mL and 0.6 and 0.9 µg/mL, respectively.
Urine analysis
The urinary concentrations of ephedrines were determined by a high-performance liquid chromatography (HPLC) method described by Chan et al. (9) . An HPLC system (Shimadzu, Kyoto, Japan) consisting of an SIL-10A autoinjector, SPD-M10AVP photodiode-array detector, LC-10AD pump, DGU-4A degasser, CTO-10A oven, and CBM-10A communications bus module was used. This method used α-ethylbenzylamine as the internal standard and a Spherisorb C 18 column for an isocratic elution in a tetraethylammonium phosphate (TEAP)/methanol (985:15, v/v) with a flow rate of 1 mL/min and monitored at 206 nm. The TEAP solution was prepared by adding 15.54 g TEAH and 2.80 g phosphoric acid with water to reach a final volume of 500 mL and adjusting the pH to 2.7 (± 0.1). A 1-mL aliquot of urine, 100 µL of diluted internal standard (20 mg/mL), 100 µL of 20% (w/v) sodium hydroxide solution, and 4 mL of diethyl ether were added into a test tube. The organic layer was removed after shaking and centrifuging. One hundred microliters of 1% (v/v) acetic acid was added to the organic layer. A residue layer of acetic acid was dissolved in 200 µL of TEAP. A 20-µL aliquot of the resulting solution was injected into the HPLC system for analysis.
Data analysis
Data obtained from a single-dose administration of six volunteers were calculated as mean plus or minus standard deviation. The excretion-rate constant k was calculated from the urinary excretion data by the amount-remaining-to-beexcreted (ARE) method, also known as the sigma-minus method (10) . The logarithm of the ARE was plotted on a semilogarithmic scale versus the time of each urine collection. The slope of this line was -k/2.3. The estimated elimination half-life of the drug was determined as 0.693/k.
Results and Discussion
This study provided the excretion evidence for ephedrines following the administration of the Sho-seiryu-to preparation and discussed the consequence for athletes in relation to doping control.
Ephedrines analysis in Sho-seiryu-to preparation
The analytical recovery, obtained with spiked Sho-seiryu-to preparation at three different amounts ranged 98.7-101.1% for E, 96.6-100.1% for PE, 93.5-99.4% for ME, 110.4-118.5% for NPE, and 101.9-122.4% for NE. The amount of E, PE, ME, NE, and NPE were determined in Sho-seiryu-to preparation. The results indicated 2984.2 µg of E, 1353.6 µg of PE, 361.9 µg of ME, 229.0 µg of NPE, and 134.6 µg of NE per 2.5 g of the Sho-seiryu-to. Among these ephedrines, E was presented with the highest amount. This result agreed with the previous studies (7, 8) . However, because ME is metabolized to E (11), only four ephedrines (without ME) were presented in the urine.
Urine ephedrines excretion profile
In Table I , the individual pH, specific gravity, as well as the concentrations of NE, NPE, E, and PE in urine, are listed. Mean urinary pH and specific gravity were 6.2 (± 0.6) and 1.0115 (± 0.0082), respectively. The mean urinary ephedrines concentration-time profiles following a single-dose administration of Sho-seiryu-to preparation were shown in Figure 1 . In the urine, the highest amount observed of these ephedrines was E [3.9 (± 1.9) µg/mL]. The ME profile was not presented in the figure because its amount in the urine was almost negligible. The urinary ephedrines appeared to peak at the 6th hour and were eliminated by the 48th hour. The concentration for each compound after a singledose treatment was lower than the WADA permitted value (10 µg/mL) (4). The urinary ephedrines cumulative excreted curve was presented in Figure 2 . The whole excretion amounts of ephedrines after administering a single-dose Sho-seiryu-to preparation were 3102.7 (± 336.3) µg for E, 1286.9 (± 121.4) µg for PE, 215.9 (± 32.8) µg for NPE, 261.0 (± 114.1) µg for NE, and 10.7 (± 26.2) µg for ME. The ratios of cumulative excreted amount to administering amount for E, PE, NPE, NE, and ME were 1.04, 0.95, 0.94, 1.94, and 0.18, respectively. The ratios of NE and ME are further away from theoretically 1.00. This is because most of the ME is metabolized to E, and E is further metabolized to NE through N-demethylation (11) . Therefore, the excretion/administration ratio of NE was the greatest and the excretion/administration ratio of ME was so small that it is negligible in the urine after the Sho-seiryu-to preparation was administered. The urinary E concentrations from multiple-dose study were listed in Table II . The concentration of E in the first specimen was 13.73 µg/mL, which exceeded the WADA-permitted value (4), but the concentrations of other specimens did not. Thus, multiple-dose administration can cause a positive doping result. Moreover, the data showed that the ingestion of 2.5 g Sho-seiryu-to preparation that contained 2984.2 µg of E resulted in a maximum urine concentration of 3.9 µg/mL of E in urine ( Figure 1 ). Based on this result, it is speculated that an individual who takes a single-dose of TCM preparation that contains 7.9 mg of ephedrine may lead to anti-doping rule violation. However, alkalinization of the urine decreases the amount of ephedrine excreted (11, 12) . On the contrast, the acidic urine will increase the ephedrine excretion. Exercise alters a number of physiological parameters including changes in cardiac output, blood flow to active skeletal muscles, kidney, and other organs, which may alter the pharmacokinetics of a drug as a result (13) . The renal plasma flow, urine excretion rate, and urine pH are reduced by exercise (14) . Therefore, after a single-dose treatment, the concentrations of urinary ephedrine for athletes may be higher than the values of this study. Athletes should be careful when taking Sho-seiryu-to preparation.
Pharmacokinetic parameters of urinary ephedrines excretion
The mean maximum concentration (C max ), time to maximum concentration (T max ) in urine and the estimated elimination half-life following administration of the Shoseiryu-to are summarized in Table III . Mean C max was 4.67 (± 2.11) µg/mL in E, 2.40 (± 1.26) µg/mL in PE, 0.58 (± 0.40) µg/mL in NE, and 0.46 (± 0.26) µg/mL in NPE, respectively. Mean half-life was 4.9 (± 0.9) h in NE, 5.4 (± 1.8) h in NPE, 5.3 (± 1.2) h in E, and 4.4 (± 1.0) h in PE. It is obvious that an interindividual variation existed after the administration of the same amount of Sho-seiryu-to and was reflected a large standard deviation.
Conclusions
The dosing regimen used in this study was designed to simulate the likely use of over-the-counter medicines for the management of upper respiratory tract condition by athletes. The result showed that ephedrine, norephedrine (phenylpropanolamine), pseudoephedrine, and norpseudoephedrine (cathine) were excreted in urine after taking a single-dose (2.5 g) of Sho-seiryu-to preparation. Our results showed that an individual taking a single therapeutic dose over a relatively short time period would not exceed the WADA cut-off levels. Nevertheless, a three times per day administration of a therapeutic dose for three days showed a positive ephedrine result in urine. In conclusion, it is important for athletes to remind their physicians not to prescribe the Sho-seiryu-to preparation for more than three days if they have to take it. Moreover, it is estimate that all the TCM preparations that contain E over 7.9 g may cause a positive ephedrine test result, which violates the WADA rules.
